Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

April 16, 2019 | Corporate News | English

Annual General Meeting 2019: Tecan shareholders endorse all motions proposed by the Board of Directors

  • Increase in the dividend from CHF 2.00 to CHF 2.10 per share
  • Lukas Braunschweiler, Heinrich Fischer, Oliver Fetzer, Lars Holmqvist, Karen Huebscher, Christa Kreuzburg and Daniel R. Marshak re-elected as members of the Board of Directors
  • Lukas Braunschweiler confirmed by shareholders as Chairman of the Board
  • Christa Kreuzburg, Oliver Fetzer and Daniel R. Marshak confirmed as members of the Compensation Committee
  • All proposals relating to compensation approved


Männedorf, Switzerland, April 16, 2019 – The Annual General Meeting of Tecan Group Ltd. (SIX Swiss Exchange: TECN) has today endorsed all motions proposed by the Board of Directors. Shareholders approved the Annual Report, the financial statements and the consolidated financial statements, and granted discharge to the Board of Directors and the Management Board. They agreed to an increase in the dividend from CHF 2.00 to CHF 2.10 per registered share. The payout will take place on April 24, 2019.

All members of the Tecan Board of Directors were confirmed by the shareholders for a term of one year: Heinrich Fischer, Dr. Oliver Fetzer, Lars Holmqvist, Dr. Karen Huebscher, Dr. Christa Kreuzburg, Dr. Daniel R. Marshak and Dr. Lukas Braunschweiler. Lukas Braunschweiler was re-elected as Chairman of the Board of Directors. The shareholders also confirmed Christa Kreuzburg, Oliver Fetzer and Daniel R. Marshak as members of the Compensation Committee.

As announced in mid-January 2019, Dr. Achim von Leoprechting succeeded Dr. David Martyr as the new CEO of Tecan on April 1, 2019. David Martyr is retiring after another very successful financial year. Lukas Braunschweiler, Chairman of the Board of Directors, warmly thanked the departing CEO on behalf of the Board for his outstanding achievements. He commented: “It was under David Martyr’s leadership that Tecan found its way back to strong growth and sharply higher profitability. It is the first time in Tecan’s history that the Board of Directors has elected an internal successor, which is firm evidence that a strong management team has been built up in recent years. Tecan is now well set up for continued successful development. We wish David Martyr all the very best in his retirement.”


Other proposals also approved
The shareholders voted on the conditions governing the compensation of the Board of Directors and Management Board for the following fiscal year, according to the Ordinance Against Excessive Compensation in Listed Stock Companies of the Swiss government (OaEC). They made a binding decision to endorse the proposed maximum total amount of compensation for fiscal year 2020 and also, for the Board of Directors, for the period until the 2020 Annual General Meeting. The 2018 Compensation Report, which was submitted for an advisory vote, was also accepted by shareholders.

Ernst & Young AG, Zurich, was reappointed as the statutory auditors for fiscal year 2019.
Shareholders approved the motion proposed by the Board of Directors to appoint Proxy Voting Services GmbH, Zurich, as the independent proxy for the period up to the close of the Tecan Group 34th Annual General Meeting in 2020.


Key upcoming date
Tecan will publish the 2019 Interim Report on August 15, 2019.


About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2018, Tecan generated sales of CHF 594 million (USD 606 million; EUR 516 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).


For further information:

Tecan Group
Martin Brändle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89